CSF from MS patients can induce acute conduction block in the isolated optic nerve

European Journal of Neurology

Volumn 12, Issue 1, 2005, Pages 45-48

  Centonze, Diego ^a,b   Rossi, S ^a   Boffa, L ^a   Versace, V ^a   Palmieri, M G ^a   Caramia, M D ^a   Bernardi, G ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

CAP; Demyelination; in vitro electrophysiology; Nerve conduction; QYNAD; Sodium channels

Indexed keywords

ION CHANNEL;

ADULT; ANIMAL TISSUE; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FEMALE; HUMAN; IN VITRO STUDY; MALE; MULTIPLE SCLEROSIS; NERVE BLOCK; NERVE CONDUCTION; NERVE POTENTIAL; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; RAT;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANIMALS; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NERVE BLOCK; NEURAL CONDUCTION; OPTIC NERVE; RATS; RATS, WISTAR; STATISTICS, NONPARAMETRIC;

EID: 12744254929     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2004.00946.x     Document Type: Article

References (19)

1. Brinkmeier H, Aulkemeyer P, Wollinsky KH, Rüdel R (2000). An endogenous pentapeptide acting as a sodium channel blocker in inflammatory autoimmune disorders of the central nervous system. Nat Med 6:808-811.
2. Cummins TR, Renganathan M, Stys PK et al. (2003). The pentapeptide QYNAD does not block voltage-gated sodium channels. Neurology 60:224-229.
3. De Stefano N, Narayanan S, Matthews PM, Francis GS, Antel JP, Arnold DL (1999). In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis. Brain 122:1933-1939.
4. Ferguson B, Matyszak MK, Esiri MM, Perry VH (1997). Axonal damage in acute multiple sclerosis lesions. Brain 120:393-399.
5. Köller H, Buchholz J, Siebler M (1996). Cerebrospinal fluid from multiple sclerosis patients inactivates neuronal Na+ current. Brain 119:457-463.
6. Köller H, Siebler M, Hartung HP (1997). Immunologically induced electrophysiological dysfunction: implications for inflammatory diseases of the CNS and PNS. Prog Neurobiol 52:1-26.
7. Kuwabara S, Yuki N, Koga M et al. (1998). IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome. Ann Neurol 44:202-208.
8. McDonald WI, Compston A, Edan G et al. (2001). Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 50:121-127.
9. Meuth SG, Budde T, Duyar H et al. (2003). Modulation of neuronal activity by the endogenous pentapeptide QY-NAD. Eur J Neurosci 18:2697-2706.
10. Moreau T, Coles A, Wing M et al. (1996). Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. Brain 119:225-237.
11. Padmashri R, Chakrabarti KS, Sahal D, Mahalakshmi R, Sarma SP, Sikdar SK (2004). Functional characterization of the pentapeptide QYNAD on rNav1.2 channels and its NMR structure. Pflugers Arch 447:895-907.
12. Poser CM, Paty DW, Scheinberg L et al. (1983). New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-231.
13. Quasthoff S, Pojer C, Mori A et al. (2003). No blocking effects of the pentapeptide QYNAD on Na+ channel subtypes expressed in Xenopus oocytes or action potential conduction in isolated rat sural nerve. Neurosci Lett 352:93-96.
14. Sakurai M, Mannen T, Kanazawa I, Tanabe H (1992). Lidocaine unmasks silent demyelinative lesions in multiple sclerosis. Neurology 42:2088-2093.
15. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L (1998). Axonal transection in the lesions of multiple sclerosis. New Engl J Med 338:278-285.
16. Waxman SG (2001). Acquired channelopathies in nerve injury and MS. Neurology 56:1621-1627.
17. Weber F, Rüdel R, Aulkemeyer P, Brinkmeier H (2000). Anti-GM1 antibodies can block voltage-gated sodium channels. Muscle Nerve 23:1414-1420.
18. Weber F, Rüdel R, Aulkemeyer P, Brinkmeier H (2002). The endogenous pentapeptide QYNAD induces acute conduction block in the isolated rat sciatic nerve. Neurosci Lett 317:33-36.
19. Wollinsky KH, Hulser PJ, Brinkmeier H et al. (2001). CSF filtration is an effective treatment of Guillain-Barré syndrome: a randomized clinical trial. Neurology 57:774-779.